生命科学资讯

MoonLake's phase 2 arthritis win kicks off pivotal year for IL-17 nanobody

Assessing Myelin Formation and Therapeutic Response Using 3D Organoids

iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson’s and First Enrollment in China’s Randomized MSA Trial for NouvNeu004

Supreme Court steps in: Trump's emergency tariffs struck down

Ionis scraps early candidate for Alzheimer’s in people with Down syndrome

Grail stock craters as key NHS-Galleri cancer blood test trial fails to hit primary endpoint

Mainz Biomed looks to shed ColoAlert, shifts focus in US

Chutes & Ladders—Roche taps Aussie oncologist to lead early research

Biohaven charts comeback path after FDA blow, placing bets on obesity

Candel glows brighter with $100M RTW royalty deal to fund prostate cancer drug's launch

Daiichi picks former Novartis CMO John Tsai to head up R&D

White House frustration may have fueled FDA’s Moderna walkback: Politico

Novartis winds down ph. 1 solid tumor program after lacking efficacy

Sanofi backs Altesa's $75M series B to bankroll antiviral's midstage rhinovirus study

Study finds blood test can predict age of Alzheimer's onset

J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy

GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research

NIH Director Jay Bhattacharya to take over as temporary CDC chief: media reports

Senate HELP Committee chair pitches proposals for FDA reform

Blood from pediatricians yields potential new medicines for respiratory viruses